R J Pomerantz

736 total citations
15 papers, 619 citations indexed

About

R J Pomerantz is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, R J Pomerantz has authored 15 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 6 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in R J Pomerantz's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (5 papers) and Immune Cell Function and Interaction (5 papers). R J Pomerantz is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (5 papers) and Immune Cell Function and Interaction (5 papers). R J Pomerantz collaborates with scholars based in United States. R J Pomerantz's co-authors include David Baltimore, Mark B. Feinberg, Didier Trono, Geethanjali Dornadula, H Zhang, Liping Duan, Joseph Kulkosky, Mohamad Bouhamdan, D S Strayer and Zhu Ming and has published in prestigious journals such as The Journal of Experimental Medicine, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

R J Pomerantz

15 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R J Pomerantz United States	13	411	245	217	186	115	15	619
Takashi Odawara Japan	15	316 0.8×	164 0.7×	239 1.1×	210 1.1×	109 0.9×	46	704
T J Matthews United States	10	494 1.2×	266 1.1×	262 1.2×	276 1.5×	155 1.3×	14	723
A.G. Laurent-Crawford France	9	542 1.3×	201 0.8×	176 0.8×	434 2.3×	224 1.9×	9	782
Kenji Ikeuchi Japan	7	383 0.9×	202 0.8×	94 0.4×	178 1.0×	105 0.9×	16	475
Tavis D. Steenbeke United States	12	546 1.3×	199 0.8×	144 0.7×	450 2.4×	130 1.1×	13	705
F Kazazi Australia	12	333 0.8×	268 1.1×	211 1.0×	234 1.3×	138 1.2×	17	838
Jennifer Jones United States	11	511 1.2×	231 0.9×	196 0.9×	388 2.1×	138 1.2×	16	837
Bernd Laffert Germany	7	567 1.4×	227 0.9×	189 0.9×	384 2.1×	135 1.2×	7	744
Philip K. Ehrenberg United States	15	546 1.3×	304 1.2×	193 0.9×	381 2.0×	143 1.2×	25	841

Countries citing papers authored by R J Pomerantz

Since Specialization

Citations

This map shows the geographic impact of R J Pomerantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R J Pomerantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R J Pomerantz more than expected).

Fields of papers citing papers by R J Pomerantz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R J Pomerantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R J Pomerantz. The network helps show where R J Pomerantz may publish in the future.

Co-authorship network of co-authors of R J Pomerantz

This figure shows the co-authorship network connecting the top 25 collaborators of R J Pomerantz. A scholar is included among the top collaborators of R J Pomerantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R J Pomerantz. R J Pomerantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Cordelier, Pierre, Chih‐Yuan Ko, JJ Rossi, et al.. (2004). Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5. Gene Therapy. 11(22). 1627–1637. 25 indexed citations

Pomerantz, R J. (2002). Reservoirs of Human Immunodeficiency Virus Type 1: The Main Obstacles to Viral Eradication. Clinical Infectious Diseases. 34(1). 91–97. 78 indexed citations

Cordelier, Pierre, Mohamad Bouhamdan, R. Paul Johnson, et al.. (2001). SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters. Gene Therapy. 8(13). 1033–1042. 16 indexed citations

Zhang, H, Geethanjali Dornadula, Jan M. Orenstein, & R J Pomerantz. (2000). Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core.. PubMed. 3(3). 165–72. 37 indexed citations

Bouhamdan, Mohamad, et al.. (2000). Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.. PubMed. 3(1). 6–15. 17 indexed citations

Zern, Mark Α., et al.. (1999). A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line. Gene Therapy. 6(1). 114–120. 44 indexed citations

Shaheen, Farida, et al.. (1999). Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.. PubMed. 2(3). 154–66. 32 indexed citations

Ho, Wen‐Zhe, Jianping Lai, Mohamad Bouhamdan, et al.. (1998). Inhibition of HIV Type 1 Replication in Chronically Infected Monocytes and Lymphocytes by Retrovirus-Mediated Gene Transfer of Anti-Rev Single-Chain Variable Fragments. AIDS Research and Human Retroviruses. 14(17). 1573–1580. 12 indexed citations

Zhang, Hui, Geethanjali Dornadula, & R J Pomerantz. (1998). Natural endogenous reverse transcription of HIV type 1.. PubMed. 14 Suppl 1. S93–5. 12 indexed citations

10.

Bagasra, Omar & R J Pomerantz. (1997). Reply. The Journal of Infectious Diseases. 176(2). 541–541a. 2 indexed citations

11.

Duan, Liping, H Zhang, Bing Hu, et al.. (1996). Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. Journal of Virology. 70(12). 8821–8832. 95 indexed citations

12.

Taylor, J. Paul, R J Pomerantz, Joseph W. Oakes, Kamel Khalili, & Shohreh Amini. (1995). A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat.. PubMed. 10(2). 395–400. 22 indexed citations

13.

Bagasra, Omar, et al.. (1992). Adenosine-deaminase-associated immunodeficiency. I. Differential sensitivities of lymphocyte subpopulations exposed to 2-deoxycoformycinin vivo. Clinical & Experimental Immunology. 88(3). 383–388. 9 indexed citations

14.

Pomerantz, R J, Mark B. Feinberg, Raul Andino, & David Baltimore. (1991). The long terminal repeat is not a major determinant of the cellular tropism of human immunodeficiency virus type 1. Journal of Virology. 65(2). 1041–1045. 31 indexed citations

15.

Pomerantz, R J, Mark B. Feinberg, Didier Trono, & David Baltimore. (1990). Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression.. The Journal of Experimental Medicine. 172(1). 253–261. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact